Cell signaling pathways associated with a reduction in mammary cancer burden by dietary common bean (Phaseolus vulgaris L.)

Carcinogenesis

Volumn 33, Issue 1, 2012, Pages 226-232

  Thompson, Matthew D ^a   Mensack, Meghan M ^b   Jiang, Weiqin ^b   Zhu, Zongjian ^b   Lewis, Matthew R ^b   McGinley, John N ^b   Brick, Mark A ^b   Thompson, Henry J ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; S6 KINASE; SOMATOMEDIN C; TRANSCRIPTION FACTOR E2F1; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER RISK; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; LIVER; NONHUMAN; OUTCOME ASSESSMENT; PHASEOLUS VULGARIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RAT; RISK REDUCTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TIME OF FLIGHT MASS SPECTROMETRY; WESTERN BLOTTING;

EID: 84855362096     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr247     Document Type: Article

References (38)

1. Geil,P.B. et al. (1994) Nutrition and health implications of dry beans: a review. J. Am. Coll. Nutr., 13, 549-558.
2. Broughton,W.J. et al. (2003) Beans (Phaseolus spp.)-model food legumes. Plant Soil, 252, 55-128.
3. Economic Research Service. (2007) Food Availability. USDA, Washington, DC.
4. U.S. Department of Agriculture. (2010) Dietary Guidelines for Americans. http://www.cnpp.usda.gov/DGAs2010-PolicyDocument.htm. (July 2011, date last accessed).
5. Adebamowo,C.A. et al. (2005) Dietary flavonols and flavonol-rich foods intake and the risk of breast cancer. Int. J. Cancer, 114, 628-633.
6. Murtaugh,M.A. et al. (2008) Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am. J. Clin. Nutr., 87, 978-984.
7. Bobe,G. et al. (2008) Dietary cooked navy beans and their fractions attenuate colon carcinogenesis in azoxymethane-induced ob/ob mice. Nutr. Cancer, 60, 373-381.
8. Mentor-Marcel,R.A. et al. (2009) Inflammation-associated serum and colon markers as indicators of dietary attenuation of colon carcinogenesis in ob/ob mice. Cancer Prev. Res. (Phila Pa), 2, 60-69.
9. Hangen,L. et al. (2002) Consumption of black beans and navy beans (Phaseolus vulgaris) reduced azoxymethane-induced colon cancer in rats. Nutr. Cancer, 44, 60-65.
10. Lanza,E. et al. (2006) High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial. J. Nutr., 136, 1896-1903.
11. Mills,P.K. et al. (1989) Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer, 64, 598-604.
12. Kolonel,L.N. et al. (2000) Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev., 9, 795-804.
13. Thompson,M.D. et al. (2009) Chemical composition and mammary cancer inhibitory activity of dry bean. Crop Sci., 49, 179-186.
14. Hanahan,D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
15. Marshall,S. (2006) Role of insulin, adipocyte hormones, and nutrientsensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci. STKE, 2006, re7.
16. Um,S.H. et al. (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab., 3, 393-402.
17. Yang,Q. et al. (2007) Expanding mTOR signaling. Cell Res., 17, 666-681.
18. Hynes,N.E. et al. (2006) The mTOR pathway in breast cancer. J. Mammary Gland Biol. Neoplasia., 11, 53-61.
19. Thompson,M.D. et al. (2008) Mechanisms associated with dose-dependent inhibition of rat mammary carcinogenesis by dry bean (Phaseolus vulgaris, L.). J. Nutr., 138, 2091-2097.
20. Thompson,H.J. et al. (1995) Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis, 16, 2407-2411.
21. Thompson,H.J. et al. (2000) Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J. Mammary Gland Biol.Neoplasia., 5, 201-210.
22. McGinley,J.N. et al. (2000) Effect of fixation and epitope retrieval on BrdU indices in mammary carcinomas. J. Histochem. Cytochem., 48, 355-362.
23. Kerr,J.F. et al. (1972) Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257.
24. Walker,N.I. et al. (1989) Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat., 185, 19-32.
25. Jiang,W. et al. (2003) Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats. Cancer Res., 63, 1228-1234.
26. Christov,K. et al. (2007) Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model. Clin. Cancer Res., 13, 5488-5496.
27. Pierce,B.L. et al. (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J. Clin. Oncol., 27, 3437-3444.
28. Howell,J.J. et al. (2011) mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol. Metab., 22, 94-102.
29. Wink,M. (2003) Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry, 64, 3-19.
30. Hardie,D.G. (2004) AMP-activated protein kinase: a master switch in glucose and lipid metabolism. Rev. Endocr. Metab. Disord., 5, 119-125.
31. Bennink,M.R. et al. (2008) Beans and Health: A Comprehensive Review. The Bean Institute, Frazee, MN, pp. 1-31.
32. Shackelford,D.B. et al. (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer, 9, 563-575.
33. Shaw,R.J. (2009) LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. (Oxf.), 196, 65-80.
34. Hardie,D.G. (2008) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond.), 32 (suppl. 4), S7-S12.
35. Hardie,D.G. (2008) AMPK and Raptor: matching cell growth to energy supply. Mol. Cell, 30, 263-265.
36. Stiles,B.L. (2009) PI-3-K and AKT: onto the mitochondria. Adv. Drug Deliv. Rev., 61, 1276-1282.
37. Efeyan,A. et al. (2010) mTOR and cancer: many loops in one pathway. Curr. Opin. Cell Biol., 22, 169-176.
38. Laplante,M. et al. (2009) An emerging role of mTOR in lipid biosynthesis. Curr. Biol., 19, R1046-R1052.